Anti‐COVID‐19 measurements for hidradenitis suppurativa patients

The reported incidence of COVID‐19 among cohorts of patients with inflammatory bowel and skin diseases under treatment with biologicals is low. Treatment may further modify disease severity as some biological modifiers, such as anakinra, are also proposed for the management of COVID‐19 patients pote...

Full description

Saved in:
Bibliographic Details
Published in:Exp Dermatol
Main Authors: Giamarellos‐Bourboulis, Evangelos J., Bettoli, Vincenzo, Jemec, Gregor B. E., del Marmol, Veronique, Marzano, Angelo V., Prens, Errol P., Tzellos, Thrasyvoulos, Zouboulis, Christos C.
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2021
Subjects:
10th European Hidradenitis Suppurativa (EHSF) e.V. Conference
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8207032/
https://ncbi.nlm.nih.gov/pubmed/34085330
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/exd.14339
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items